Supreme Court Rejects Plea Alleging Side Effects Of COVID-19 Vaccines

New Delhi:  The Supreme Court of India on Monday dismissed a petition alleging that COVID-19 vaccines caused severe side effects, including blood clotting, calling the plea as an attempt to create unnecessary alarm.

A bench led by Chief Justice DY Chandrachud, along with Justices JB Pardiwala and Manoj Misra, declined to entertain the petition, stating that it lacked merit. “We don’t want to rake this up. This is just to create a sensation,” remarked the bench, questioning the usefulness of the petition.

The court further highlighted the broader implications, suggesting that public health efforts might have been compromised if people had refrained from taking the vaccine.

During the proceedings, the court directly questioned the petitioner’s lawyer on whether he had taken the vaccine. After confirming that he had received the vaccine and experienced no side effects, the bench emphasized the lack of merit in the case.

The petition was filed by Priya Mishra and others, who sought to challenge the alleged adverse effects of the COVID-19 vaccination drive.

Case Details: PRIYA MISHRA AND ANR. vs UNION OF INDIA AND ORS., Diary No. 22945-2024

Related Posts

Three arrested after liquor bottles found at pharma firm

Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

Anton Paar India hosted the first day of NEXUS 2026 at Ramada by Wyndham, Navi Mumbai, bringing together leading experts, scientists, researchers and industry professionals from the pharmaceutical sector for…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Three arrested after liquor bottles found at pharma firm

Three arrested after liquor bottles found at pharma firm

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two